Inrig Jula Insider Trading Activity
Inrig Jula has been net-selling over the last 12 months with 0 purchases and 11 sales across 1 company.
TVTX is the most-traded position with 11 trades. The largest single transaction was a sale of TVTX for $900K on May 4, 2026.
Performance Scorecard
Forward stock performance after each transaction by Inrig Jula. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +8.8% | 67% | 12 |
| 90 days | — | -19.5% | 33% | 9 |
| 120 days | — | -36.7% | 14% | 7 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersTVTX · Travere Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Inrig Jula bought and sold TVTX.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 6, 2026 | TVTX | Sell | 311 | $43.95 | $14K | −0.3% | CHIEF MEDICAL OFFICER | |
May 5, 2026 | TVTX | Sell | 2,174 | $46.65 | $101K | −1.9% | CHIEF MEDICAL OFFICER | |
May 4, 2026 | TVTX | Sell | 20,000 | $45.00 | $900K | −15.2% | CHIEF MEDICAL OFFICER | |
Apr 15, 2026 | TVTX | Sell | 1,018 | $42.61 | $43K | −0.9% | CHIEF MEDICAL OFFICER | |
Apr 14, 2026 | TVTX | Sell | 7,215 | $41.93 | $303K | −6.0% | CHIEF MEDICAL OFFICER | |
Feb 4, 2026 | TVTX | Sell | 232 | $32.85 | $8K | −0.2% | CHIEF MEDICAL OFFICER | |
Feb 4, 2026 | TVTX | Sell | 1,547 | $32.11 | $50K | −1.4% | CHIEF MEDICAL OFFICER | |
Feb 3, 2026 | TVTX | Sell | 6,956 | $32.12 | $223K | −6.1% | CHIEF MEDICAL OFFICER | |
Jan 6, 2026 | TVTX | Sell | 445 | $37.75 | $17K | −0.5% | CHIEF MEDICAL OFFICER | |
Jan 5, 2026 | TVTX | Sell | 2,031 | $40.18 | $82K | −2.3% | CHIEF MEDICAL OFFICER | |
Dec 24, 2025 Filed 3d late | TVTX | Sell | 15,000 | $42.00 | $630K | −14.5% | CHIEF MEDICAL OFFICER | |
Jul 1, 2025 | TVTX | Sell | 815 | $14.65 | $12K | −0.9% | CHIEF MEDICAL OFFICER |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | 12 | $2.4M |
Other insiders at Travere Therapeutics, Inc.
7 other tracked filers at TVTX.